Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BoneSupport" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BoneSupport for you to read. Along with our medical data and news we also list BoneSupport Clinical Trials, which are updated daily. BioPortfolio also has a large database of BoneSupport Companies for you to search.
Edison Investment Research - Pharmaceutical & healthcare - Bonesupport: BONESUPPORT is commercialising synthetic bone graft substitutes. The company invests in R&D to support continued development of innovative products that command premium pricing and differentiate them in a competitive market. Following recent issues with the exclusive, long-standing distributor in the US, BONESUPPORT termin...
Sweden-based BoneSupport said it will augment the market penetration of its antibiotic-eluting Cerament V and Cerament G prod -More-
Edison Investment Research - Pharmaceutical & healthcare - Bonesupport: During its Q218 results presentation, Bonesupport provided an update on its US commercial platform. It is working to secure distributor contracts so that sales can commence as soon as Zimmer’s exclusivity period ends on 20 October 2018. In Europe, (where all three products are marketed) trauma surgeons are showing strong...
Health Canada has granted Sweden-based Bonesupport approval for the Cerament G gentamicin-eluting injectable ceramic bone gra -More-
BoneSupport AB Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by e...
SummaryBoneSupport AB BoneSupport is a medical technology company with focus on injectable osteoconductive biomaterials. It develops, manufactures and markets injectable bone substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infection, disease or related to surgical procedures such as benign tumors, fracture malunion and others. The ...